Adam L Orr
Works at
Sources: reporter.nih.gov
Grants and prizes
RF1, Developing Inhibitors of Mitochondrial Complex III-Derived ROS for the Treatment of Alzheimer's Disease, RF1AG095161, 2026–2030, 31 Jul 2026
R01, Complex III-derived reactive oxygen species in mitochondrial-nuclear crosstalk in Alzheimer's disease and related dementias, R01AG095960, 2025–2030, 8 Jun 2026
Sources: reporter.nih.gov